ExpiresFebruary 12, 2021
National Comprehensive Cancer Network
To provide optimal patient care, clinicians need to be well informed about the latest clinical research updates and how these advances compare to the current standard of care for patients with breast cancer. In order to inform decision-making and formulate breast cancer management strategies, clinicians need up-to-date information and opportunities to apply this information through case-based learning. NCCN has identified gaps in the ability of practicing oncologists, radiologists, pathologists, nurses, and other health care professionals who provide care for patients with cancer to stay updated regarding the current guidelines for the management of breast cancer, recent studies of therapies for the treatment of breast cancer, and selection of the best treatment strategies for these patients. This activity will improve the level of care provided by diplomates caring for patients with breast cancer by educating them on the latest updates to the NCCN guidelines for treating this patient population.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
Medical Genetics and Genomics
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Summarize the current standards of oncology care, key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), and clinical research updates from the 2020 SABCS, and integrate appropriate strategies into clinical practice to optimize the management of patients with breast cancer and improve patient outcomes.
· Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of patients with breast cancer.
Understanding/Addressing Health Disparities to Improve Breast Cancer Care
· Review the diverse spectrum of socioeconomic issues contributing to disparities in access to and delivery of breast cancer care.
· Describe the effect of tumor biology and genetics on breast cancer risk and outcomes of treatment.
· Apply methods and strategies that provide equitable access to timely and high-quality breast cancer care to clinical practice.
Genetic Testing in Patients with Breast Cancer: Who Should Get Tested?
· Identify genes that are associated with an increased risk of hereditary breast cancer.
· Review current genetic testing criteria for patients with breast cancer.
· Recognize the challenges associated with genetic testing for patients with breast cancer.
Surgical and Radiation Treatment Updates to Management of Breast Cancer, Including SABCS Updates
· Develop an evidence-based approach for the surgical management of the axilla in patients with early stage breast cancer.
· Individualize radiation therapy recommendations based on patient and tumor characteristics.
· Discuss new and emerging data in the management of patients with early stage breast cancer and integrate key findings into clinical practice.
Adjuvant and Neoadjuvant Therapies for Breast Cancer, Including SABCS Updates
· Compare and contrast data on the clinical safety and efficacy of neoadjuvant regimens in early stage breast cancer.
· Recognize key patient and clinical factors that influence selection of systemic adjuvant therapy.
· Discuss clinical data of new and emerging supportive care interventions to enhance shared decision-making and improve quality of life of patients undergoing neoadjuvant/adjuvant chemotherapy.
Breast Cancer in Young Adults: Treatment Considerations and Supportive Care Options
· Review the breast cancer risk factors and tumor characteristics unique to the adolescent and young adult (AYA) population.
· Compare and contrast the various treatment modalities for the management of breast cancer in young adults.
· Recognize the supportive care issues unique to the AYA population and manage patients accordingly.
Updates to the Systemic Treatment of Metastatic Breast Cancer, Including SABCS Updates
· Select evidence-based first- and subsequent-line treatment options for patients with metastatic breast cancer based on hormone- and HER2-receptor status.
· Review the current therapeutic approaches for triple negative metastatic breast cancer.
· As appropriate, incorporate new and emerging therapeutic options into the management of patients with metastatic breast cancer.
Management of Breast Cancer Brain Metastases
· Recognize the frequency of brain metastases in patients with breast cancer and presenting signs and symptoms of metastases.
· Review the efficacy and potential effects on cognitive function and quality of life related to local treatment of brain metastases, such as stereotactic radiosurgery and whole brain radiation therapy.
· Identify systemic therapy options for patients with brain metastases from breast cancer.
Breast Cancer Survivors: Issues and Recommendations
· List some of the more common physical, psychological, and psychosocial late and long-term effects associated with breast cancer and its treatment.
· Counsel breast cancer survivors about healthy lifestyle changes that can decrease the risks for many late and long-term effects.
· Develop strategies for screening and management of common late and long-term effects in breast cancer survivors.
Academic, Community, Radiology, Pathology
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills
CME Credit Type
AMA PRA Category 1 Credit
Academic Medicine, Inpatient, Outpatient, Rural, Urban